Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.

Lu PW, Li L, Wang F, Gu YT

Open source

DOI
10.1002/jcp.27066
Published
2019 Feb
Container
Journal of cellular physiology
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jcp.27066,
  title = {Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.},
  author = {Lu PW and Li L and Wang F and Gu YT},
  year = {2019},
  journal = {Journal of cellular physiology},
  doi = {10.1002/jcp.27066},
  url = {https://doi.org/10.1002/jcp.27066}
}

RIS

TY  - JOUR
TI  - Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
AU  - Lu PW
AU  - Li L
AU  - Wang F
AU  - Gu YT
PY  - 2019
JO  - Journal of cellular physiology
DO  - 10.1002/jcp.27066
UR  - https://doi.org/10.1002/jcp.27066
ER  - 

APA

PW, L., L, L., F, W., & YT, G. (2019). Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.. Journal of cellular physiology. https://doi.org/10.1002/jcp.27066

Source records